Even as an OTC company, we saw it back in July alone hit 3.29. There are OTC stocks out there in double digit land. So, Generex even as an OTC stock having a high PPS is not out of the question.
However, once Generex gets (if) funding, then the PPS rises past 2.00, then they can push to the NASDAQ and the Investors will come. Then it's a new ballgame all over.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links